CD36 and fatty liver disease: Taken together, the protective effects of Curc-mPEG454 against hepatic steatosis are possibly via specific inhibition of PPAR-γ/CD36 pathway activation and subsequent reduction of FFA uptake and TG synthesis in the liver.